Rosekind, Ehsani and Michael published a June 2020 Commentary in JAMA Internal Medicine calling for more data to inform policies needed to reduce impaired driving fatalities. Although we are a strong proponent of more data for that purpose, we took issue with two of the authors’ specific recommendations:
- More crash risk studies like the NHTSA-sponsored Virginia Beach study, and
- Improved FARS data.
JAMA Internal Medicine published our disagreements and the authors’ response Nov. 16, 2020:… READ MORE